KALA BIO, Inc. reports

Company location: Arlington, MA
Fiscal year end: 31 December

KALA BIO, Inc. has filed 666 SEC EDGAR filings since 23 Dec 2009

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 276-300 of 665 matching filings.

Per page

25

Current page

12

8-K File 001-38150

8-K

Filing date: 10 Jan 2023
Reporting date: 09 Jan 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 06 Jan 2023
Reporting date: 04 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Jan 2023
Reporting date: 04 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Jan 2023
Reporting date: 04 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Jan 2023
Reporting date: 04 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Jan 2023
Reporting date: 04 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Jan 2023
Reporting date: 04 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-269114

S-8

Filing date: 04 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38150

FORM 8-K

Filing date: 27 Dec 2022
Reporting date: 27 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38150

FORM 8-K

Filing date: 09 Dec 2022
Reporting date: 05 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38150

8-K

Filing date: 28 Nov 2022
Reporting date: 28 Nov 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-38150

10-Q

Filing date: 08 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38150

8-K

Filing date: 08 Nov 2022
Reporting date: 08 Nov 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 01 Nov 2022
Reporting date: 31 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 01 Nov 2022
Reporting date: 31 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38150

8-K

Filing date: 01 Nov 2022
Reporting date: 31 Oct 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 28 Oct 2022
Reporting date: 26 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 28 Oct 2022
Reporting date: 26 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 28 Oct 2022
Reporting date: 26 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 28 Oct 2022
Reporting date: 26 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 28 Oct 2022
Reporting date: 26 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38150

8-K

Filing date: 20 Oct 2022
Reporting date: 19 Oct 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEF 14A File 001-38150

DEF 14A

Filing date: 09 Sep 2022
Reporting date: 19 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

PRE 14A File 001-38150

PRE 14A

Filing date: 30 Aug 2022
Reporting date: 19 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38150

8-K

Filing date: 19 Aug 2022
Reporting date: 18 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .